LOGO
LOGO

Quick Facts

GoodRx Q3 Net Loss Narrows, Adj. EPS Meets View; Sees Higher Q4 Revenues, Cuts FY23 Outlook

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

GoodRx Holdings, Inc. (GDRX), a resource for healthcare savings and information, reported Thursday that its third-quarter net loss was $38.50 million, compared to a net loss of $41.73 million last year. Loss per share was $0.09, narrower than prior year's loss of $0.10 per share.

Adjusted net income was $25.5 million or $0.06 per share, compared to prior year's adjusted net income of $29.9 million or $0.07 per share.

Analysts on average also expected the company to report earnings of $0.06 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

Revenue decreased 4 percent to $179.96 million from $187.32 million a year ago, primarily due to a $10.0 million contract termination payment to a client.

Adjusted revenue increased 1 percent to $189.96 million, primarily driven by growth in prescription transactions revenue.

The Street was looking for revenues of $188.28 million for the quarter.

Looking ahead for the fourth quarter, the company projects revenue on a reported and adjusted basis in the range of $188 million to $194 million, representing 2 percent-5 percent year-over-year growth.

Adjusted EBITDA Margin for the quarter is expected to be in the mid-to-high twenty-percent range.

For fiscal 2023, the company now projects revenue in the range of $742 million to $748 million, representing a decline of 3 percent to 2 percent. Adjusted revenue would be between $752 million and $758 million, representing a decline of 2 percent to 1 percent.

The company previously expected fiscal 2023 total revenue of approximately $750 million to $760 million.

The analysts expect revenues of $192.67 million for the fourth quarter and $754.99 million for fiscal 2023.

In pre-market activity on Nasdaq, GoodRx shares were trading at $5.25, down 4.02 percent.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.